162 related articles for article (PubMed ID: 22433286)
1. Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study.
Gardner CJ; Irwin AJ; Daousi C; McFarlane IA; Joseph F; Bell JD; Thomas EL; Adams VL; Kemp GJ; Cuthbertson DJ
Eur J Endocrinol; 2012 Jun; 166(6):993-1002. PubMed ID: 22433286
[TBL] [Abstract][Full Text] [Related]
2. Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement.
Meienberg F; Yee M; Johnston D; Cox J; Robinson S; Bell JD; Thomas EL; Taylor-Robinson SD; Godsland I
Clin Endocrinol (Oxf); 2016 Jul; 85(1):76-84. PubMed ID: 26895949
[TBL] [Abstract][Full Text] [Related]
3. Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle.
Cuthbertson DJ; Irwin A; Sprung VS; Jones H; Pugh CJ; Daousi C; Adams VL; Bimson WE; Shojaee-Moradie F; Richardson P; Umpleby AM; Wilding JP; Kemp GJ
Clin Sci (Lond); 2014 Dec; 127(12):655-63. PubMed ID: 24738611
[TBL] [Abstract][Full Text] [Related]
4. The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study.
Egger A; Buehler T; Boesch C; Diem P; Stettler C; Christ ER
Eur J Endocrinol; 2011 Jan; 164(1):23-9. PubMed ID: 20930061
[TBL] [Abstract][Full Text] [Related]
5. Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.
Christ ER; Egger A; Allemann S; Buehler T; Kreis R; Boesch C
Sci Rep; 2016 Jan; 6():19310. PubMed ID: 26792091
[TBL] [Abstract][Full Text] [Related]
6. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
[TBL] [Abstract][Full Text] [Related]
7. Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise.
Loher H; Jenni S; Bucher J; Krüsi M; Kreis R; Boesch C; Christ E
Growth Horm IGF Res; 2018; 42-43():32-39. PubMed ID: 30153529
[TBL] [Abstract][Full Text] [Related]
8. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study.
Thomas EL; Hamilton G; Patel N; O'Dwyer R; Doré CJ; Goldin RD; Bell JD; Taylor-Robinson SD
Gut; 2005 Jan; 54(1):122-7. PubMed ID: 15591516
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.
Brigante G; Diazzi C; Ansaloni A; Zirilli L; Orlando G; Guaraldi G; Rochira V
Eur J Endocrinol; 2014 May; 170(5):685-96. PubMed ID: 24536088
[TBL] [Abstract][Full Text] [Related]
10. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease.
Mehta SR; Godsland IF; Thomas EL; Pavitt DV; Morin SX; Bell JD; Taylor-Robinson SD; Johnston DG
J Clin Endocrinol Metab; 2012 Jun; 97(6):2151-9. PubMed ID: 22442265
[TBL] [Abstract][Full Text] [Related]
12. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
13. Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency.
Ferrante E; Malavazos AE; Giavoli C; Ermetici F; Coman C; Bergamaschi S; Profka E; Briganti S; Ronchi CL; Passeri E; Corbetta S; Lania AG; Spada A; Iacobellis G; Ambrosi B; Beck-Peccoz P
Nutr Metab Cardiovasc Dis; 2013 May; 23(5):459-65. PubMed ID: 22118958
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.
Nishizawa H; Iguchi G; Murawaki A; Fukuoka H; Hayashi Y; Kaji H; Yamamoto M; Suda K; Takahashi M; Seo Y; Yano Y; Kitazawa R; Kitazawa S; Koga M; Okimura Y; Chihara K; Takahashi Y
Eur J Endocrinol; 2012 Jul; 167(1):67-74. PubMed ID: 22535644
[TBL] [Abstract][Full Text] [Related]
15. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
[TBL] [Abstract][Full Text] [Related]
18. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
19. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
[TBL] [Abstract][Full Text] [Related]
20. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic Traits.
Brand T; van den Munckhof ICL; van der Graaf M; Schraa K; Dekker HM; Joosten LAB; Netea MG; Riksen NP; de Graaf J; Rutten JHW
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3881-e3889. PubMed ID: 34137897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
